283 related articles for article (PubMed ID: 35998078)
1. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.
de Rooij LPMH; Becker LM; Teuwen LA; Boeckx B; Jansen S; Feys S; Verleden S; Liesenborghs L; Stalder AK; Libbrecht S; Van Buyten T; Philips G; Subramanian A; Dumas SJ; Meta E; Borri M; Sokol L; Dendooven A; Truong AK; Gunst J; Van Mol P; Haslbauer JD; Rohlenova K; Menter T; Boudewijns R; Geldhof V; Vinckier S; Amersfoort J; Wuyts W; Van Raemdonck D; Jacobs W; Ceulemans LJ; Weynand B; Thienpont B; Lammens M; Kuehnel M; Eelen G; Dewerchin M; Schoonjans L; Jonigk D; van Dorpe J; Tzankov A; Wauters E; Mazzone M; Neyts J; Wauters J; Lambrechts D; Carmeliet P
Cardiovasc Res; 2023 Mar; 119(2):520-535. PubMed ID: 35998078
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
EBioMedicine; 2022 Aug; 82():104185. PubMed ID: 35870428
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
[TBL] [Abstract][Full Text] [Related]
5. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
6. In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naïve B cells as a trigger for severe immune responses in the lungs of COVID-19 patients.
Wu YY; Wang SH; Wu CH; Yen LC; Lai HF; Ho CL; Chiu YL
PLoS One; 2020; 15(12):e0242900. PubMed ID: 33264345
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.
Pehote G; Vij N
Cells; 2020 Aug; 9(9):. PubMed ID: 32847034
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs.
Carraro G; Mulay A; Yao C; Mizuno T; Konda B; Petrov M; Lafkas D; Arron JR; Hogaboam CM; Chen P; Jiang D; Noble PW; Randell SH; McQualter JL; Stripp BR
Am J Respir Crit Care Med; 2020 Dec; 202(11):1540-1550. PubMed ID: 32692579
[No Abstract] [Full Text] [Related]
9. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung.
Schupp JC; Adams TS; Cosme C; Raredon MSB; Yuan Y; Omote N; Poli S; Chioccioli M; Rose KA; Manning EP; Sauler M; DeIuliis G; Ahangari F; Neumark N; Habermann AC; Gutierrez AJ; Bui LT; Lafyatis R; Pierce RW; Meyer KB; Nawijn MC; Teichmann SA; Banovich NE; Kropski JA; Niklason LE; Pe'er D; Yan X; Homer RJ; Rosas IO; Kaminski N
Circulation; 2021 Jul; 144(4):286-302. PubMed ID: 34030460
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Wendisch D; Dietrich O; Mari T; von Stillfried S; Ibarra IL; Mittermaier M; Mache C; Chua RL; Knoll R; Timm S; Brumhard S; Krammer T; Zauber H; Hiller AL; Pascual-Reguant A; Mothes R; Bülow RD; Schulze J; Leipold AM; Djudjaj S; Erhard F; Geffers R; Pott F; Kazmierski J; Radke J; Pergantis P; Baßler K; Conrad C; Aschenbrenner AC; Sawitzki B; Landthaler M; Wyler E; Horst D; ; Hippenstiel S; Hocke A; Heppner FL; Uhrig A; Garcia C; Machleidt F; Herold S; Elezkurtaj S; Thibeault C; Witzenrath M; Cochain C; Suttorp N; Drosten C; Goffinet C; Kurth F; Schultze JL; Radbruch H; Ochs M; Eils R; Müller-Redetzky H; Hauser AE; Luecken MD; Theis FJ; Conrad C; Wolff T; Boor P; Selbach M; Saliba AE; Sander LE
Cell; 2021 Dec; 184(26):6243-6261.e27. PubMed ID: 34914922
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
Das A; Meng W; Liu Z; Hasib MM; Galloway H; Ramos da Silva S; Chen L; Sica GL; Paniz-Mondolfi A; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Rivera KP; Flores M; Chiu YC; Huang Y; Gao SJ
J Med Virol; 2023 Aug; 95(8):e29009. PubMed ID: 37563850
[TBL] [Abstract][Full Text] [Related]
12. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
[TBL] [Abstract][Full Text] [Related]
13. The networks of m
Li X; Peng C; Zhu Z; Cai H; Zhuang Q
Aging (Albany NY); 2021 Mar; 13(5):6273-6288. PubMed ID: 33647885
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
Kim SK; Jung SM; Park KS; Kim KJ
BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
[TBL] [Abstract][Full Text] [Related]
16. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
17. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis.
Huang Y; Guzy R; Ma SF; Bonham CA; Jou J; Schulte JJ; Kim JS; Barros AJ; Espindola MS; Husain AN; Hogaboam CM; Sperling AI; Noth I
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36725082
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
[TBL] [Abstract][Full Text] [Related]
19. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation.
Jyothula SSK; Peters A; Liang Y; Bi W; Shivshankar P; Yau S; Garcha PS; Yuan X; Akkanti B; Collum S; Wareing N; Thandavarayan RA; Poli de Frias F; Rosas IO; Zhao B; Buja LM; Eltzschig HK; Huang HJ; Karmouty-Quintana H
EBioMedicine; 2022 Dec; 86():104351. PubMed ID: 36375315
[TBL] [Abstract][Full Text] [Related]
20. Spatially distinct molecular patterns of gene expression in idiopathic pulmonary fibrosis.
Blumhagen RZ; Kurche JS; Cool CD; Walts AD; Heinz D; Fingerlin TE; Yang IV; Schwartz DA
Respir Res; 2023 Nov; 24(1):287. PubMed ID: 37978501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
